Medicure Signs Agreement with Reliance Life Sciences for Marketing Rights of a Cardiovascular Biosimilar

Shots:

• Medicure is responsible for the regulatory approval process for the product
• The agreement grants an exclusive right to Medicure to market & sell the product in the US, Canada & the EU
• The product fits well with Medicure’s mission of being a significant CV company focused on the US market

Click here to­ read the full press release/ article | Ref: Medicure | Image: CNW Group